The aim of this study was to investigate whether TGF-β1 SNP genotypes, as modifiers of CF lung disease, can be associated with a faster decline in pulmonary function, higher TGF-β1 expression, higher Pa infection rates and elevated levels of proinflammatory cytokines in sputum. Here, TGFB1 is linked to cystic fibrosis.